- Home
- CSTM vs MNKD Comparison
CSTM vs MNKD Comparison
Compare CSTM & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTM
- MNKD
- Stock Information
- Founded
- CSTM 2010
- MNKD 1991
- Country
- CSTM France
- MNKD United States
- Employees
- CSTM N/A
- MNKD N/A
- Industry
- CSTM Metal Fabrications
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- CSTM Industrials
- MNKD Health Care
- Exchange
- CSTM Nasdaq
- MNKD Nasdaq
- Market Cap
- CSTM 1.4B
- MNKD 1.6B
- IPO Year
- CSTM 2013
- MNKD 2004
- Fundamental
- Price
- CSTM $8.60
- MNKD $4.54
- Analyst Decision
- CSTM Buy
- MNKD Buy
- Analyst Count
- CSTM 4
- MNKD 6
- Target Price
- CSTM $19.50
- MNKD $8.92
- AVG Volume (30 Days)
- CSTM 1.7M
- MNKD 2.2M
- Earning Date
- CSTM 04-30-2025
- MNKD 05-07-2025
- Dividend Yield
- CSTM N/A
- MNKD N/A
- EPS Growth
- CSTM N/A
- MNKD N/A
- EPS
- CSTM 0.38
- MNKD 0.10
- Revenue
- CSTM $7,335,000,000.00
- MNKD $285,504,000.00
- Revenue This Year
- CSTM $10.50
- MNKD $14.23
- Revenue Next Year
- CSTM $8.82
- MNKD $14.56
- P/E Ratio
- CSTM $22.63
- MNKD $45.40
- Revenue Growth
- CSTM N/A
- MNKD 43.50
- 52 Week Low
- CSTM $7.33
- MNKD $3.97
- 52 Week High
- CSTM $22.00
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- CSTM 40.32
- MNKD 28.12
- Support Level
- CSTM $7.33
- MNKD $4.34
- Resistance Level
- CSTM $8.71
- MNKD $4.72
- Average True Range (ATR)
- CSTM 0.68
- MNKD 0.21
- MACD
- CSTM -0.05
- MNKD -0.01
- Stochastic Oscillator
- CSTM 41.91
- MNKD 27.03
About CSTM Constellium SE (France)
Constellium SE is engaged in the design and manufacture of rolled and extruded aluminium products, serving the packaging, aerospace, automotive, defence and other transportation and industry end-markets. The business is organized into three operating segments: i) Packaging and Automotive Rolled Products segment which includes the production of rolled aluminium products in European and North American facilities. ii) Aerospace and Transportation segment includes the production of rolled aluminium products and very limited volumes of extruded products in European and North American facilities. iii) The Automotive Structures and Industry segment includes the production of extruded aluminium products and aluminium structural components.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.